Salvador Federico Calaf, MD
Nephrology · Saint Paul
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 18 years
- University of Texas Medical Branch at Galveston, 2008
Offices
3 locations · Group Health Inc · Nephrology Associates
Looking this up.
Hospitals listed: 052601 · 552550 · 552689 · Adventist Health Mendocino Coast · Adventist Health Ukiah Valley · Providence Santa Rosa Memorial Hospital · Sutter Lakeside Hospital · Sutter Santa Rosa Regional Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Calaf’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A131449 · Current
Licensed to practise in California · since 2014 · expires 2028-01-31 · University of Texas Medical Branch at Galveston.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Nephrology
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health Mendocino CoastFort Bragg, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 5 of 5 · 80% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
- Adventist Health Ukiah ValleyUkiah, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 7.9 (5.8 to 10.5) · 253 cases, Jan 2024 – Dec 2024
- Providence Santa Rosa Memorial HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.375, Oct 2024 – Sep 2025
- Sutter Lakeside HospitalLakeport, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Sutter Santa Rosa Regional HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Mendocino Coast
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for heart failure patientsComplications and deaths | 9 · 63 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.2 · 103 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 268 cases | None | Jul 2024 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 78 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -24.2 · 83 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.7 · 102 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 101 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.7 (5.2 to 11.1) · 65 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.5 (7.3 to 14.6) · 65 cases | No different | Jan 2024 – Dec 2024 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.8 to 17.4) · 526 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 48 cases | No different | Jan 2024 – Dec 2024 |
What patients said (119 patients answered, 22% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 5 |
| Communication about medicines | 4 |
| Discharge information | 5 |
| Overall hospital rating | 5 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 86% |
| Nurses "always" communicated well | 86% |
| Doctors "always" communicated well | 89% |
| Staff "always" explained | 72% |
| Yes, staff "did" give patients this information | 94% |
| Yes, staff "did" give patients information about help after discharge | 94% |
| Doctors "always" explained things so they could understand | 85% |
| Doctors "always" listened carefully | 87% |
| Doctors "always" treated them with courtesy and respect | 96% |
| Patients who gave a rating of "9" or "10" (high) | 86% |
| Staff "always" explained new medications | 87% |
| Nurses "always" explained things so they could understand | 82% |
| Nurses "always" listened carefully | 84% |
| Nurses "always" treated them with courtesy and respect | 92% |
| "Always" quiet at night | 56% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 57% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
See every measure and the patient survey for Adventist Health Ukiah Valley
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.9 (5.8 to 10.5) · 253 cases | Worse | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.92 (0 to 1.95) · 319 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.51 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.9 · 137 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 74 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 647 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,093 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.51) · 2,081 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.64 (2.23 to 7.05) · 328 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 99 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.45 (0.79 to 4.11) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.96 (0 to 15.74) · 117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.32 (2.24 to 10.4) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.17) · 119 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.29 (0 to 1.2) · 1,614 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.891 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.607 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.396 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 114 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.9 · 171 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 6.5 · 270 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 234 cases | None | Jul 2023 – Jun 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.4 (8 to 13.6) · 253 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 37 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.4 to 17.4) · 1,320 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 361 cases | No different | Jan 2024 – Dec 2024 |
What patients said (341 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 33% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Providence Santa Rosa Memorial Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.19 (0.26 to 2.13) · 1,736 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.48 to 1.03) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.27 (137.92 to 224.62) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 129 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 530 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.2 · 448 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.3 · 245 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 2,733 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.4) · 8,115 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,057 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.37 (0.56 to 4.18) · 2,186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0.1 to 3.08) · 772 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.9 to 3.63) · 1,999 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.74 (0.06 to 11.42) · 810 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.04 (0.53 to 7.55) · 768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.8 (0.38 to 3.21) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.46 (0 to 1) · 7,051 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 77 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.915 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.552 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.297 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.353 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 288 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 489 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.4 · 259 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.4 · 580 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.5 · 456 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 431 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.4 (4.9 to 8.3) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.3 (8.2 to 12.7) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.8 to 16.7) · 2,810 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 780 cases | No different | Jan 2024 – Dec 2024 |
What patients said (473 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Sutter Lakeside Hospital
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 1 better, 5 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for COPD patientsComplications and deaths | 8.7 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 94 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 133 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 379 cases | None | Jul 2024 – Jun 2025 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 31 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 1.249 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 72 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -25.4 · 92 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -37.9 · 137 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 109 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 47 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.3) · 564 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 52 cases | No different | Jan 2024 – Dec 2024 |
What patients said (209 patients answered, 18% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 83% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 70% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 82% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 63% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 58% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Sutter Santa Rosa Regional Hospital
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.157 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0.08 to 1.99) · 1,147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.69 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.53 (108.3 to 216.76) · 54 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 316 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 296 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 142 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,971 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.06 to 0.47) · 4,946 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,974 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.99 (2.93 to 7.06) · 1,288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0 to 3.15) · 532 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (0.82 to 3.9) · 1,214 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.87 (2.35 to 17.39) · 558 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.01 (4.29 to 11.73) · 522 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.05) · 337 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.18 (0 to 0.89) · 4,064 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 206 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.626 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.299 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 342 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.1 · 184 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14 · 352 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -17.4 · 309 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.2 · 309 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.2 (5.1 to 9.8) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (8.8 to 15) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 215 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.8 to 18) · 1,275 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 702 cases | No different | Jan 2024 – Dec 2024 |
What patients said (752 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$230,836
Medicare paid this office $230,836 for 496 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 61 | $95,210 | $264 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 180 | $43,391 | $88 |
| Dialysis services, 1 physician visit per month (20 years or older) | 37 | $27,490 | $154 |
| Home dialysis services per month (20 years or older) | 16 | $15,162 | $217 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 31 | $13,448 | $207 |
See all 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 61 | $95,210 | $264 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 180 | $43,391 | $88 |
| Dialysis services, 1 physician visit per month (20 years or older) | 37 | $27,490 | $154 |
| Home dialysis services per month (20 years or older) | 16 | $15,162 | $217 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 31 | $13,448 | $207 |
| Return visit (30+ min) | 179 | $13,398 | $48 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 83 | $12,355 | $127 |
| Critical care, first 30-74 minutes | 20 | $5,916 | $156 |
| New patient visit (45+ min) | 33 | $3,376 | $102 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $293 | $20 |
| Telephone medical discussion with physician, 5-10 minutes | 15 | $235 | $16 |
Who their Medicare patients are
496 Original Medicare patients in 2024. Average age 71 · Under 65 20% · 85 and older 10% · Women 42% · Also on Medicaid 49% · Health risk score 4.99. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 60% · Heart failure 50% · Coronary heart disease 44% · Atrial fibrillation 35% · Depression 29% · COPD 25% · Stroke 17% · Cancer 15% · Dementia 9%.
The office billed $479,020, Medicare allowed $310,175 and paid $230,836; for 1,656 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 496 | 1,656 | 71 | 4.99 | $479,020 | $230,836 |
| 2023 | 427 | 1,595 | 71 | 4.94 | $430,039 | $254,560 |
| 2022 | 412 | 1,581 | 71 | 4.41 | $409,203 | $246,989 |
| 2021 | 462 | 1,576 | 70 | 4.57 | $371,143 | $223,492 |
| 2020 | 407 | 1,502 | 71 | 4.93 | $347,078 | $211,990 |
| 2019 | 449 | 1,905 | 70 | 4.81 | $359,448 | $218,759 |
| 2018 | 448 | 2,833 | 71 | 4.65 | $341,111 | $218,074 |
| 2017 | 404 | 2,309 | 69 | 4.88 | $289,184 | $181,820 |
| 2016 | 381 | 3,525 | 69 | 4.74 | $284,674 | $177,594 |
| 2015 | 362 | 3,229 | 69 | 4.99 | $281,279 | $176,548 |
| 2014 | 104 | 386 | 69 | 4.79 | $41,212 | $26,686 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 38 | $62,005 | $305 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 142 | $47,000 | $101 |
| Home dialysis services per month (20 years or older) | 25 | $45,497 | $254 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 65 | $45,076 | $238 |
| Dialysis services, 1 physician visit per month (20 years or older) | 46 | $21,797 | $168 |
| Return visit (30+ min) | 132 | $11,834 | $53 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 53 | $8,042 | $139 |
| New patient visit (45+ min) | 41 | $5,812 | $142 |
| Critical care, first 30-74 minutes | 14 | $5,546 | $179 |
| Telephone medical discussion with physician, 11-20 minutes | 33 | $843 | $23 |
| Telephone medical discussion with physician, 5-10 minutes | 19 | $328 | $15 |
2022: 11 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 66 | $77,022 | $250 |
| Home dialysis services per month (20 years or older) | 27 | $47,030 | $251 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 155 | $37,554 | $85 |
| Dialysis services, 1 physician visit per month (20 years or older) | 54 | $35,229 | $164 |
| Return visit (30+ min) | 139 | $21,258 | $102 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 75 | $12,693 | $157 |
| Critical care, first 30-74 minutes | 17 | $7,003 | $180 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 14 | $4,423 | $316 |
| New patient visit (45+ min) | 14 | $1,781 | $127 |
| Telephone medical discussion with physician, 11-20 minutes | 33 | $1,450 | $40 |
| Telephone medical discussion with physician, 5-10 minutes | 20 | $674 | $26 |
2021: 11 services
| Dialysis services, 1 physician visit per month (20 years or older) | 55 | $50,764 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 170 | $44,436 | $87 |
| Home dialysis services per month (20 years or older) | 23 | $37,955 | $251 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 61 | $30,348 | $249 |
| Return visit (30+ min) | 114 | $18,237 | $105 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 76 | $13,643 | $164 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 20 | $12,066 | $309 |
| New patient visit (45+ min) | 48 | $6,441 | $134 |
| Critical care, first 30-74 minutes | 16 | $4,445 | $171 |
| Telephone medical discussion with physician, 11-20 minutes | 36 | $1,908 | $45 |
| Telephone medical discussion with physician, 5-10 minutes | 36 | $1,183 | $26 |
2020: 11 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 65 | $55,520 | $204 |
| Dialysis services, 1 physician visit per month (20 years or older) | 59 | $35,661 | $148 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 143 | $33,754 | $90 |
| Home dialysis services per month (20 years or older) | 24 | $31,717 | $199 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 28 | $18,462 | $240 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $13,912 | $172 |
| Return visit (30+ min) | 98 | $10,450 | $77 |
| Critical care, first 30-74 minutes | 18 | $5,073 | $188 |
| New patient visit (45+ min) | 21 | $2,877 | $137 |
| Telephone medical discussion with physician, 11-20 minutes | 58 | $2,552 | $40 |
| Telephone medical discussion with physician, 5-10 minutes | 24 | $707 | $26 |
2019: 11 services
| Dialysis services, 1 physician visit per month (20 years or older) | 72 | $60,160 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 150 | $38,929 | $86 |
| Return visit (30+ min) | 156 | $22,672 | $78 |
| Home dialysis services per month (20 years or older) | 25 | $21,062 | $190 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 16 | $19,601 | $236 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 34 | $19,209 | $198 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 78 | $14,563 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $8,851 | $60 |
| Critical care, first 30-74 minutes | 18 | $5,142 | $177 |
| New patient visit (45+ min) | 36 | $4,837 | $134 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $2,035 | $113 |
2018: 13 services
| Dialysis services, 1 physician visit per month (20 years or older) | 46 | $42,930 | $151 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 32 | $29,421 | $225 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 128 | $28,763 | $85 |
| Return visit (30+ min) | 151 | $22,119 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 80 | $19,695 | $58 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 43 | $19,465 | $193 |
| Home dialysis services per month (20 years or older) | 15 | $17,861 | $188 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $11,829 | $158 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 13 | $8,391 | None |
| New patient visit (45+ min) | 41 | $5,284 | $129 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $5,246 | $103 |
| Hemodialysis procedure with physician evaluation | 32 | $3,572 | $60 |
| Injection of drug or substance under skin or into muscle | 13 | $564 | $18 |
2017: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 47 | $42,850 | $222 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 99 | $22,093 | $84 |
| Return visit (30+ min) | 122 | $21,784 | $77 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 39 | $19,890 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 91 | $17,798 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 64 | $11,756 | $161 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 42 | $5,777 | $107 |
| New patient visit (45+ min) | 46 | $5,464 | $119 |
| Dialysis services, 1 physician visit per month (20 years or older) | 18 | $4,680 | $146 |
| Hemodialysis procedure with physician evaluation | 49 | $4,189 | $57 |
| Injection of drug or substance under skin or into muscle | 11 | $585 | $22 |
2016: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 40 | $36,983 | $224 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 98 | $19,725 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 86 | $18,590 | $58 |
| Return visit (30+ min) | 108 | $18,422 | $79 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 20 | $18,332 | None |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 41 | $15,618 | $190 |
| Dialysis services, 1 physician visit per month (20 years or older) | 20 | $10,824 | $142 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 63 | $10,575 | $158 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 42 | $5,316 | $111 |
| New patient visit (45+ min) | 40 | $5,198 | $130 |
| Critical care, first 30-74 minutes | 12 | $4,503 | $180 |
| Hemodialysis procedure with physician evaluation | 42 | $4,428 | $59 |
| Injection of drug or substance under skin or into muscle | 20 | $1,293 | $21 |
2015: 14 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 43 | $53,980 | $227 |
| Dialysis services, 1 physician visit per month (20 years or older) | 24 | $17,276 | $150 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 30 | $16,250 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 89 | $14,822 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 83 | $14,819 | $84 |
| Return visit (30+ min) | 80 | $14,113 | $81 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 31 | $11,908 | $189 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $8,339 | $160 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $4,744 | $105 |
| Critical care, first 30-74 minutes | 14 | $4,023 | $175 |
| Hemodialysis procedure with physician evaluation | 40 | $3,630 | $59 |
| New patient visit (45+ min) | 30 | $3,456 | $115 |
| Injection of drug or substance under skin or into muscle | 29 | $1,292 | $21 |
| Short return visit (20+ min) | 12 | $837 | $49 |
2014: 5 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 25 | $10,180 | $231 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $3,489 | $58 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 16 | $3,313 | $195 |
| Return visit (30+ min) | 25 | $2,284 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $2,264 | $84 |
Medicaid work
$46,173 in 2024
Medicaid paid $46,173 for 892 billed services this clinician did in 2024, up to 38 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 222 | $21,550 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 446 | $13,703 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 87 | $6,084 |
| Return visit (30+ min) | 87 | $2,642 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 24 | $1,424 |
| 1ST HOSP IP/OBS HIGH 75 | 26 | $769 |
| 2024 | 892 | 6 | 38 | $46,173 |
| 2023 | 1,049 | 6 | 28 | $45,919 |
| 2022 | 1,063 | 7 | 36 | $52,109 |
| 2021 | 894 | 5 | 29 | $34,894 |
| 2020 | 726 | 5 | 37 | $52,479 |
| 2019 | 190 | 5 | 25 | $11,111 |
| 2018 | 34 | 1 | 12 | $1,823 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 551 | $18,842 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 103 | $8,430 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 139 | $7,220 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 122 | $6,161 |
| Return visit (30+ min) | 102 | $2,634 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 32 | $2,633 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 239 | $22,528 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 432 | $13,418 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 138 | $8,155 |
| Return visit (30+ min) | 141 | $3,318 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 87 | $2,481 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 14 | $1,656 |
| 1ST HOSP IP/OBS HIGH 75 | 12 | $553 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 230 | $13,678 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 519 | $12,447 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 61 | $6,955 |
| Return visit (30+ min) | 58 | $1,355 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 26 | $458 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 242 | $30,118 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 308 | $8,849 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 126 | $8,341 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 34 | $4,542 |
| Return visit (30+ min) | 16 | $630 |
2019
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 62 | $4,338 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 20 | $2,342 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 71 | $2,009 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 13 | $1,791 |
| Return visit (30+ min) | 24 | $630 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 34 | $1,823 |
Drugs they prescribed that Part D paid
$398,458
Pharmacies billed $398,458 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,215) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
1,019 generic and fewer than 11 brand-name prescriptions · $398,458 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Farxiga | 44 | $49,976 | $1,136 |
| Jardiance | 32 | $41,310 | $1,291 |
| Lokelma | 32 | $40,273 | $1,259 |
| Veltassa | 24 | $33,665 | $1,403 |
| Sevelamer Carbonate | 66 | $23,954 | $363 |
See all 30 drugs
| Farxiga | 44 | $49,976 | $1,136 |
| Jardiance | 32 | $41,310 | $1,291 |
| Lokelma | 32 | $40,273 | $1,259 |
| Veltassa | 24 | $33,665 | $1,403 |
| Sevelamer Carbonate | 66 | $23,954 | $363 |
| Cinacalcet | 14 | $10,625 | $759 |
| Sps | 16 | $9,696 | $606 |
| Dapagliflozin | 14 | $6,899 | $493 |
| Calcium Acetate | 24 | $3,982 | $166 |
| Nifedipine Er | 41 | $2,423 | $59 |
| Torsemide | 75 | $1,887 | $25 |
| Allopurinol | 122 | $1,573 | $13 |
| Bumetanide | 17 | $918 | $54 |
| Losartan | 64 | $665 | $10 |
| Amlodipine Besylate | 89 | $619 | $7 |
| Furosemide | 34 | $433 | $13 |
| Tamsulosin | 16 | $422 | $26 |
| Irbesartan | 14 | $393 | $28 |
| Metoprolol | 29 | $349 | $12 |
| Lisinopril | 34 | $334 | $10 |
| Calcitriol | 26 | $320 | $12 |
| Potassium Chloride | 18 | $312 | $17 |
| Gabapentin | 22 | $278 | $13 |
| Hydralazine | 16 | $250 | $16 |
| Prednisone | 32 | $248 | $8 |
| Metolazone | 14 | $246 | $18 |
| Carvedilol | 39 | $230 | $6 |
| Hydrochlorothiazide | 22 | $111 | $5 |
| Benazepril | 12 | $100 | $8 |
| Clonidine | 16 | $51 | $3 |
Year by year
| 2024 | 1,215 | 251 | 0% (0) | None | $398,458 |
| 2023 | 1,131 | 216 | 0% (0) | None | $324,943 |
| 2022 | 1,210 | 206 | 0% (0) | 11% | $233,613 |
| 2021 | 1,075 | 204 | 0% (0) | 9% | $158,762 |
| 2020 | 1,149 | 200 | 0% (0) | 11% | $200,514 |
| 2019 | 1,323 | 231 | None | 14% | $243,121 |
| 2018 | 1,335 | 232 | None | None | $199,789 |
| 2017 | 1,221 | 232 | None | None | $313,469 |
| 2016 | 1,146 | 178 | None | None | $379,501 |
| 2015 | 838 | 148 | None | None | $164,626 |
| 2014 | 126 | 46 | 0% (0) | 31% | $7,553 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 28 drugs
| Sevelamer Carbonate | 47 | $30,496 | $649 |
| Lokelma | 30 | $30,014 | $1,000 |
| Farxiga | 21 | $28,173 | $1,342 |
| Veltassa | 22 | $26,609 | $1,210 |
| Nulojix | 13 | $24,513 | $1,886 |
| Jardiance | 11 | $19,429 | $1,766 |
| Torsemide | 94 | $4,798 | $51 |
| Calcium Acetate | 34 | $3,485 | $102 |
| Bumetanide | 16 | $2,848 | $178 |
| Allopurinol | 96 | $2,425 | $25 |
| Nifedipine Er | 21 | $2,222 | $106 |
| Irbesartan | 31 | $1,907 | $62 |
| Amlodipine Besylate | 89 | $1,651 | $19 |
| Doxazosin Mesylate | 12 | $1,292 | $108 |
| Losartan | 61 | $1,053 | $17 |
| Carvedilol | 44 | $1,035 | $24 |
| Calcitriol | 38 | $980 | $26 |
| Furosemide | 57 | $840 | $15 |
| Chlorthalidone | 19 | $838 | $44 |
| Lisinopril | 39 | $673 | $17 |
| Potassium Chloride | 16 | $485 | $30 |
| Omeprazole | 11 | $469 | $43 |
| Metoprolol | 14 | $465 | $33 |
| Spironolactone | 11 | $357 | $32 |
| Gabapentin | 15 | $333 | $22 |
| Lidocaine-Prilocaine | 11 | $150 | $14 |
| Hydrochlorothiazide | 11 | $94 | $9 |
| Sodium Chloride | 13 | $34 | $3 |
2022: 25 drugs
| Veltassa | 43 | $42,599 | $991 |
| Sevelamer Carbonate | 55 | $25,196 | $458 |
| Sps | 38 | $11,340 | $298 |
| Bumetanide | 26 | $5,931 | $228 |
| Calcium Acetate | 39 | $5,845 | $150 |
| Torsemide | 92 | $4,063 | $44 |
| Nifedipine Er | 18 | $2,031 | $113 |
| Allopurinol | 98 | $2,024 | $21 |
| Mycophenolate Mofetil | 14 | $1,437 | $103 |
| Irbesartan | 35 | $1,343 | $38 |
| Calcitriol | 40 | $1,343 | $34 |
| Chlorthalidone | 25 | $1,267 | $51 |
| Carvedilol | 63 | $1,064 | $17 |
| Amlodipine Besylate | 117 | $1,043 | $9 |
| Losartan | 55 | $693 | $13 |
| Furosemide | 50 | $590 | $12 |
| Doxazosin Mesylate | 12 | $581 | $48 |
| Lisinopril | 33 | $548 | $17 |
| Clonidine | 22 | $395 | $18 |
| Metoprolol | 15 | $378 | $25 |
| Gabapentin | 16 | $362 | $23 |
| Lactulose | 11 | $337 | $31 |
| Potassium Chloride | 22 | $295 | $13 |
| Benazepril | 13 | $249 | $19 |
| Hydrochlorothiazide | 12 | $104 | $9 |
2021: 31 drugs
| Veltassa | 20 | $19,005 | $950 |
| Sevelamer Carbonate | 56 | $13,367 | $239 |
| Lanthanum Carbonate | 12 | $11,740 | $978 |
| Phoslyra | 13 | $7,178 | $552 |
| Sps | 22 | $5,454 | $248 |
| Calcium Acetate | 28 | $4,852 | $173 |
| Bumetanide | 18 | $4,636 | $258 |
| Torsemide | 63 | $3,199 | $51 |
| Allopurinol | 80 | $1,948 | $24 |
| Doxazosin Mesylate | 18 | $1,493 | $83 |
| Amlodipine Besylate | 99 | $1,377 | $14 |
| Carvedilol | 66 | $1,325 | $20 |
| Mycophenolate Mofetil | 12 | $1,173 | $98 |
| Nifedipine Er | 23 | $1,155 | $50 |
| Calcitriol | 36 | $951 | $26 |
| Irbesartan | 24 | $757 | $32 |
| Chlorthalidone | 19 | $612 | $32 |
| Losartan | 30 | $556 | $19 |
| Furosemide | 37 | $551 | $15 |
| Potassium Chloride | 20 | $494 | $25 |
| Hydralazine | 16 | $451 | $28 |
| Ropinirole | 21 | $397 | $19 |
| Gabapentin | 20 | $374 | $19 |
| Ondansetron Odt | 14 | $324 | $23 |
| Omeprazole | 16 | $284 | $18 |
| Hydrochlorothiazide | 23 | $244 | $11 |
| Lisinopril | 33 | $237 | $7 |
| Clonidine | 17 | $219 | $13 |
| Benazepril | 18 | $205 | $11 |
| Promethazine | 11 | $133 | $12 |
| Metoprolol | 13 | $115 | $9 |
2020: 34 drugs
| Auryxia | 11 | $35,844 | $3,259 |
| Veltassa | 29 | $26,419 | $911 |
| Nulojix | 13 | $24,529 | $1,887 |
| Sevelamer Carbonate | 61 | $16,017 | $263 |
| Cinacalcet | 16 | $12,607 | $788 |
| Lanthanum Carbonate | 11 | $12,101 | $1,100 |
| Bumetanide | 15 | $4,515 | $301 |
| Torsemide | 102 | $4,418 | $43 |
| Calcium Acetate | 29 | $3,996 | $138 |
| Midodrine | 31 | $3,660 | $118 |
| Allopurinol | 82 | $2,049 | $25 |
| Mycophenolate Mofetil | 16 | $1,334 | $83 |
| Nifedipine Er | 23 | $1,294 | $56 |
| Amlodipine Besylate | 89 | $1,108 | $12 |
| Doxazosin Mesylate | 14 | $1,013 | $72 |
| Febuxostat | 12 | $993 | $83 |
| Irbesartan | 16 | $987 | $62 |
| Metoprolol | 22 | $968 | $44 |
| Carvedilol | 69 | $835 | $12 |
| Chlorthalidone | 15 | $596 | $40 |
| Furosemide | 53 | $518 | $10 |
| Calcitriol | 27 | $492 | $18 |
| Clonidine | 21 | $398 | $19 |
| Hydralazine | 11 | $387 | $35 |
| Omeprazole | 16 | $378 | $24 |
| Lisinopril | 35 | $338 | $10 |
| Potassium Chloride | 11 | $317 | $29 |
| Benazepril | 24 | $293 | $12 |
| Ondansetron Odt | 18 | $268 | $15 |
| Losartan | 20 | $267 | $13 |
| Hydrochlorothiazide | 13 | $154 | $12 |
| Metoprolol | 19 | $147 | $8 |
| Atorvastatin | 14 | $97 | $7 |
| Promethazine | 19 | $82 | $4 |
2019: 32 drugs
| Renvela | 25 | $49,875 | $1,995 |
| Sevelamer Carbonate | 83 | $47,862 | $577 |
| Auryxia | 19 | $26,560 | $1,398 |
| Nulojix | 13 | $25,276 | $1,944 |
| Veltassa | 28 | $25,156 | $898 |
| Lanthanum Carbonate | 14 | $9,031 | $645 |
| Uloric | 12 | $4,161 | $347 |
| Calcium Acetate | 58 | $4,039 | $70 |
| Bumetanide | 22 | $3,928 | $179 |
| Torsemide | 88 | $3,313 | $38 |
| Allopurinol | 91 | $2,089 | $23 |
| Doxazosin Mesylate | 23 | $1,560 | $68 |
| Metolazone | 12 | $1,537 | $128 |
| Amlodipine Besylate | 113 | $1,273 | $11 |
| Midodrine | 14 | $956 | $68 |
| Nifedipine Er | 27 | $921 | $34 |
| Chlorthalidone | 19 | $890 | $47 |
| Carvedilol | 78 | $887 | $11 |
| Potassium Chloride | 29 | $792 | $27 |
| Clonidine | 36 | $635 | $18 |
| Furosemide | 52 | $585 | $11 |
| Calcitriol | 38 | $564 | $15 |
| Metoprolol | 14 | $544 | $39 |
| Mycophenolate Mofetil | 13 | $474 | $36 |
| Losartan | 34 | $411 | $12 |
| Hydralazine | 21 | $359 | $17 |
| Lisinopril | 37 | $350 | $9 |
| Benazepril | 21 | $341 | $16 |
| Omeprazole | 15 | $129 | $9 |
| Metoprolol | 11 | $70 | $6 |
| Ciprofloxacin | 11 | $36 | $3 |
| Promethazine | 18 | $36 | $2 |
2018: 31 drugs
| Renvela | 48 | $74,743 | $1,557 |
| Sevelamer Carbonate | 39 | $25,775 | $661 |
| Nulojix | 12 | $23,442 | $1,953 |
| Auryxia | 17 | $15,694 | $923 |
| Veltassa | 13 | $9,773 | $752 |
| Calcium Acetate | 53 | $2,589 | $49 |
| Torsemide | 85 | $2,531 | $30 |
| Allopurinol | 102 | $1,711 | $17 |
| Clonidine | 23 | $1,298 | $56 |
| Nifedipine Er | 24 | $1,230 | $51 |
| Chlorthalidone | 27 | $1,220 | $45 |
| Amlodipine Besylate | 109 | $863 | $8 |
| Doxazosin Mesylate | 14 | $848 | $61 |
| Losartan | 46 | $793 | $17 |
| Potassium Chloride | 37 | $733 | $20 |
| Midodrine | 24 | $714 | $30 |
| Metoprolol | 18 | $689 | $38 |
| Carvedilol | 93 | $581 | $6 |
| Calcitriol | 25 | $471 | $19 |
| Furosemide | 61 | $447 | $7 |
| Spironolactone | 21 | $416 | $20 |
| Irbesartan | 24 | $345 | $14 |
| Hydralazine | 19 | $281 | $15 |
| Tamsulosin | 13 | $240 | $18 |
| Hydrochlorothiazide | 17 | $235 | $14 |
| Clonidine | 29 | $234 | $8 |
| Lisinopril | 26 | $198 | $8 |
| Benazepril | 13 | $171 | $13 |
| Atorvastatin | 11 | $161 | $15 |
| Lactulose | 12 | $152 | $13 |
| Metoprolol | 13 | $86 | $7 |
2017: 30 drugs
| Sensipar | 73 | $121,213 | $1,660 |
| Renvela | 56 | $96,462 | $1,723 |
| Nulojix | 13 | $25,820 | $1,986 |
| Veltassa | 15 | $12,909 | $861 |
| Torsemide | 100 | $2,606 | $26 |
| Chlorthalidone | 29 | $1,439 | $50 |
| Clonidine | 11 | $1,363 | $124 |
| Calcium Acetate | 15 | $1,187 | $79 |
| Amlodipine Besylate | 103 | $1,071 | $10 |
| Potassium Chloride | 42 | $813 | $19 |
| Allopurinol | 42 | $812 | $19 |
| Carvedilol | 81 | $651 | $8 |
| Furosemide | 87 | $631 | $7 |
| Nifedipine Er | 23 | $555 | $24 |
| Metoprolol | 11 | $531 | $48 |
| Cartia Xt | 11 | $502 | $46 |
| Gabapentin | 14 | $475 | $34 |
| Losartan | 45 | $425 | $9 |
| Irbesartan | 15 | $402 | $27 |
| Minoxidil | 14 | $330 | $24 |
| Tamsulosin | 19 | $325 | $17 |
| Atorvastatin | 15 | $314 | $21 |
| Valsartan | 13 | $298 | $23 |
| Hydrochlorothiazide | 29 | $290 | $10 |
| Calcitriol | 22 | $286 | $13 |
| Benazepril | 16 | $257 | $16 |
| Spironolactone | 11 | $197 | $18 |
| Lisinopril | 18 | $143 | $8 |
| Metoprolol | 11 | $94 | $9 |
| Sodium Chloride | 12 | $26 | $2 |
2016: 27 drugs
| Sensipar | 143 | $210,759 | $1,474 |
| Renvela | 65 | $92,058 | $1,416 |
| Veltassa | 19 | $12,149 | $639 |
| Renagel | 11 | $11,834 | $1,076 |
| Torsemide | 79 | $2,141 | $27 |
| Clinisol | 11 | $1,901 | $173 |
| Calcium Acetate | 14 | $1,653 | $118 |
| Klor-Con M20 | 11 | $1,114 | $101 |
| Nifedipine Er | 29 | $991 | $34 |
| Chlorthalidone | 19 | $975 | $51 |
| Furosemide | 88 | $911 | $10 |
| Amlodipine Besylate | 88 | $905 | $10 |
| Kionex | 17 | $903 | $53 |
| Losartan | 38 | $578 | $15 |
| Lisinopril | 51 | $556 | $11 |
| Allopurinol | 25 | $553 | $22 |
| Carvedilol | 49 | $479 | $10 |
| Hydralazine | 24 | $394 | $16 |
| Tamsulosin | 20 | $353 | $18 |
| Benazepril | 31 | $348 | $11 |
| Atorvastatin | 12 | $304 | $25 |
| Valsartan | 12 | $288 | $24 |
| Prednisone | 13 | $225 | $17 |
| Potassium Chloride | 13 | $221 | $17 |
| Metoprolol | 19 | $218 | $11 |
| Hydrochlorothiazide | 19 | $205 | $11 |
| Spironolactone | 13 | $189 | $15 |
2015: 20 drugs
| Sensipar | 71 | $93,189 | $1,313 |
| Renvela | 39 | $41,787 | $1,071 |
| Calcium Acetate | 16 | $1,617 | $101 |
| Losartan | 54 | $1,289 | $24 |
| Torsemide | 50 | $1,032 | $21 |
| Chlorthalidone | 18 | $897 | $50 |
| Sps | 12 | $893 | $74 |
| Furosemide | 103 | $828 | $8 |
| Amlodipine Besylate | 83 | $695 | $8 |
| Tamsulosin | 21 | $469 | $22 |
| Lisinopril | 47 | $364 | $8 |
| Diltiazem Er | 12 | $309 | $26 |
| Hydralazine | 19 | $275 | $14 |
| Atorvastatin | 14 | $273 | $20 |
| Potassium Chloride | 14 | $252 | $18 |
| Hydrochlorothiazide | 20 | $192 | $10 |
| Gabapentin | 26 | $177 | $7 |
| Carvedilol | 13 | $152 | $12 |
| Allopurinol | 14 | $151 | $11 |
| Metoprolol | 11 | $143 | $13 |
2014: 4 drugs
| Losartan | 15 | $266 | $18 |
| Atorvastatin | 12 | $146 | $12 |
| Furosemide | 25 | $123 | $5 |
| Amlodipine Besylate | 13 | $73 | $6 |
Money from drug and device companies
$28 in 2025
| 2025 | 1 | 2 | None | $28 |
| 2024 | 1 | 1 | None | $35 |
| 2023 | 2 | 3 | None | $52 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Travere Therapeutics | Filspari | $28 | 2 payments
|
See all 2 published payments
| Travere Therapeutics | Meals · 2025-08-12 | None | $6 |
| Travere Therapeutics | Meals · 2025-06-09 | Filspari | $22 |
See earlier years (2024, 2023)
2024: $35
| Baxter Healthcare | Renal - Pd | $35 | 1 payment
|
2023: $52
| Travere Therapeutics | None | $28 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $25 | 1 payment
|
Professional record
- NPI
- 1053572156
- Licence
- CA A131449California A131449: Current · expires 2028-01-31
- Trained
- University of Texas Medical Branch at Galveston, 2008 · 18 years ago
- Group
- Group Health Inc · Nephrology Associates
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Orthopedic surgery (207X00000X); Federal specialty code 174400000X (174400000X)
- Mailing address
- 8170 33rd Ave S # Ms 21110q, Bloomington, MN, 55425
- NPI first listed
- 2008-06-20
- NPI last updated
- 2026-05-19
- NPI record certified
- 2026-05-19
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 205 Wabasha St S, Saint Paul, MN, 55107